How gut bacteria can be an ally in cancer treatment: An emerging paradigm
In a new forum article in the journal Cell Metabolism, Rachel Newsome, Ph.D., and Christian Jobin, Ph.D., highlighted a paradigm shift in the field.
Posts tagged as
Christian Jobin
Sleep deprivation disrupts gut microbiota, worsening colorectal cancer outcomes
The gut microbiota drives changes to the immune system caused by chronic sleep loss, the study found.
Gut bacteria molecule boosts lung cancer treatment response
A small compound produced naturally by gut bacteria doubled the response to lung cancer immunotherapy treatment in mice.
How $500 million in Gatorade royalties fuels innovation in Florida
Christian Jobin, Ph.D., wrote a column in the Tampa Bay Times on how Gatorade royalties have propelled innovation in his microbiome research.
Christian Jobin, Ph.D., comments on study exploring role of gut bacteria in early-onset colorectal cancer
Christian Jobin, Ph.D., shared his expertise with NPR on how gut bacteria damage may play a role in early-onset colorectal cancer.
Rachel Newsome, Ph.D., wins American Gastroenterological Association abstract awardÂ
Rachel Newsome will present her research on harnessing the gut microbiome to enhance the effectiveness of cancer immunotherapy treatment.
Rachel Newsome receives Thomas H. Maren Research Excellence Award
The award funds her research that harnesses gut microbiota in cancer immunotherapy response.
March is Colorectal Cancer Awareness Month
Learn about the latest research on colorectal cancer and get resources.
UF microbiome expert named UF Distinguished Professor
Christian Jobin, Ph.D., is the first distinguished professor in the UF Department of Medicine.
Common food poison toxin speeds colon cancer spread, UF researchers find
A toxin in the bacteria that’s one of the most common causes of foodborne illness accelerates the spread of colorectal tumors, a new study found.
